Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator

Details for Australian Patent Application No. 2004247384 (hide)

Owner Novartis AG

Inventors Hinterding, Klaus; Ehrhardt, Claus

Agent Davies Collison Cave

Pub. Number AU-B-2004247384

PCT Pub. Number WO2004/110979

Priority 0313612.4 12.06.03 GB

Filing date 11 June 2004

Wipo publication date 23 December 2004

Acceptance publication date 28 February 2008

International Classifications

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

C07C 217/72 (2006.01) Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

C07F 9/09 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/6574 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

22 December 2005 PCT application entered the National Phase

  PCT publication WO2004/110979 Priority application(s): WO2004/110979

28 February 2008 Application Accepted

  Published as AU-B-2004247384

26 June 2008 Standard Patent Sealed

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004247389-New benzamides as PPARY modulators

2004247377-Anthranylamide pyridones that inhibit VEGFR-2 and VEGFR-3